Felodipine-metoprolol combination tablet: A valuable option to initiate antihypertensive therapy?

American Journal of Hypertension

Volumn 12, Issue 9 I, 1999, Pages 915-920

  Waeber, Bernard ^a   Detry, Jean Marie ^b   Dahlöf, Björn ^c   Puig, Juan G ^d   Gundersen, Torstein ^e   Hosie, James ^f   Januszewicz, Wlodzimierz ^g   Lindström, Carl J ^h   Magometschnigg, Dieter ⁱ   Safar, Michel ^j   Tanser, Paul ^k   Toutouzas, Pavlos ^l  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e Med Avd   (Norway)

^f Great Western Medical   (United Kingdom)

^g MEDICAL UNIVERSITY OF WARSAW   (Poland)

^h Västra Nylands Kretssjukhus   (Finland)

ⁱ Institute of Hypertoniker   (Austria)

^j HÔPITAL BROUSSAIS   (France)

^k ST JOSEPH S HOSPITAL   (Canada)

^l HIPPOKRATION HOSPITAL   (Greece)

more..

Author keywords

Blocker; Antihypertensive efficacy; Dihydropyridine; First line therapy; Fixed dose combination; Hypertension; Quality of life; Tolerability

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FELODIPINE PLUS METOPROLOL; PLACEBO;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; EDEMA; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; TREATMENT PLANNING; VERTIGO;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENALAPRIL; FELODIPINE; FEMALE; HUMANS; HYPERTENSION; MALE; METOPROLOL; MIDDLE AGED; TABLETS; TREATMENT OUTCOME;

EID: 0032887042     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00067-9     Document Type: Article

References (27)

1. MacMahon S, Peto R, Cutler J, et al: Blood pressure, stroke, and coronary heart disease. Part I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression, dilution bias. Lancet 1990;335:765-777.
2. Collins R, Peto R, MacMahon S, et al: Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827-838.
3. Burt VL, Cutler JA, Higgins M, et al: Trends in prevalence, awareness, treatment and control of hypertension in the adult US population: data from the health examination surveys 1960-1991. Hypertension 1995;26: 60-69.
4. Mancia G, Sega R, Milesi C, et al: Blood pressure control in the hypertensive population. Lancet 1997;349: 454-457.
5. Lüscher TF, Vetter H, Siegenthaler W, Vetter W: Compliance in hypertension: facts and concepts. J Hypertens 1985;3(suppl 1):3-9.
6. 1993 Guidelines for the Management of Mild Hypertension: Memorandum from a World Health Organization/International Society of Hypertension Meeting. Hypertension 1993;22:392-403.
7. Brunner HR, Ménard J, Waeber B, et al: Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and fixed-dose combinations. J Hypertens 1990;8:3-11.
8. Waeber B, Brunner HR: Main objectives and new aspects of combination treatment of hypertension. J Hypertens 1995;13(suppl 2):S15-S19.
9. Epstein M: Newer approaches to antihypertensive therapy. Arch Intern Med 1996;156:1969-1978.
10. Todd PA, Faulds D: Felodipine. A review of the pharmacology and therapeutic use of the extended-release formulation in cardiovascular disorder. Drugs 1992;44: 251-277.
11. Houtzagers JJR, Smilde JG, Creytens G, Westergren G: Efficacy and tolerability of a new controlled-release formulation of metoprolol: a comparison with conventional metoprolol tablets in mild to moderate hypertension. Eur J Clin Pharmacol 1997;33:39-44.
12. Todd PA, Heel RC: 1986. Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs 31:198-248.
13. Dahlöf B, Jönsson L, Borgholst O, et al: Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone. Blood Pressure 1993;2(suppl1):37-45.
14. Abrahamsson B, Edgar B, Lidman K, Wingstrand K: Design and pharmacokinetics of Logimax, a new extended-release combination tablet of felodipine and metoprolo. Blood Pressure 1993;2(suppl 1);10-15.
15. Venables TL, Akhtar W, Campbell LM, et al: Antihypertensive efficacy of a combination of felodipine and metoprolol. J Hum Hypertens 1995;9(suppl 2);53.
16. Meredith PA: Through/peak ratios for antihypertensive agents. The issues in perspective. Drugs 1994;48: 661-666.
17. Gavras I, Gavras H: Enalapril, in Messerli, FH (ed): Cardiovascular Drug Therapy. Philadelphia, WB Saunders, 1990, pp 792-799.
18. MacFadyen RJ, Meredith PA, Elliott HL: Enalapril: clinical pharmacokinetics and pharmacokinetic-pharmacodynamic relationships. An overview. Clin Pharmacokinetics 1993;25:274-282.
19. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Low-dose captopril for the treatment of mild to moderate hypertension. Hypertension 1983;5(suppl 3):139-144.
20. Chrysant SG, for the Lisinopril-Hydrochlorothiazide Group: Antihypertensive effectiveness of a low-dose lisinopril-hydrochlorothiazide combination. Arch Intern Med 1994;154:737-743.
21. Gennari C, Nami R, Pavese G, et al: Calcium-channel blockade (nitrendipine) in combination with ACE inhibition (captopril) in the treatment of mild to moderate hypertension. Drugs Ther 1989;3:319-325.
22. Fitscha P, Meisner W, Hitzenberger G: Antihypertensive effects of isradipine and captopril as monotherapy or in combination. Am J Hypertens 1991;4:151s-153s.
23. Frishman WH, Bryzinski BS, Coulson LR, et al: A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994;154:1461-1468.
24. Fenichel RR, Lipicky RJ: Combination products as first-line pharmacotherapy. Arch Intern Med 1994;154: 1429-1430.
25. Krönig B, Pittrow DB, Kirch W, et al, for the German Reserpine in Hypertension Study Group, 1997: Different concepts in first-line treatment of essential hypertension: comparison of a low-dose reserpine-thiazide combination with nitrendipine monotherapy. Hypertension 1997;29:651-658.
26. Hansson L, Zanchetti A, for the HOT Study Group: The Hypertension Optimal Treatment (HOT) Study - patient characteristics: randomization, risk profiles, and early blood pressure results. Blood Pressure 1994;3: 322-327.
27. Fagan TC: Remembering the lessons of basic pharmacology. Arch Intern Med 1994;154:1430-1431.